Senior Director, Global Analytics & Insights, Cell Therapy

At AstraZeneca, every one of our employees makes a difference to patient lives every day. Each of us believes that science can change lives and to deliver this takes many people with many skill sets. When we deliver a life-changing medicine, that success comes from the combined efforts of all our people.  Within the AstraZeneca Cell Therapy Enterprise , our ambition is to realize the full potential of cell therapy for people living with cancer, immune-mediated and rare diseases around the world. This unit has responsibility for the value chain from discovery through to late-stage development and commercialization. We are rapidly progressing a broad pipeline of cell therapies in collaboration with AstraZeneca’s Therapeutic Area Units.    The Global Analytics & Insights mission is to improve the quality of decisions for our assets and across our disease areas by providing high-quality market, customer, and competitor analytics. The Senior Director, Global Analytics & Insights, Cell Therapy , will report to the Global Commercial Head, Cell Therapy, and lead a program of insights and analysis for the Cell Therapy Enterprise, supporting priority assets from clinical development through commercialization across prioritized disease areas. In addition, the role will provide deep insights and strategic direction in support of enterprise-level initiatives and key commercial decisions.  Who You Are  You bring an independent, objective, and future-oriented point of view— comfortable building the analytical foundation for a new modality rather than inheriting an established one. You move fluidly between rigorous quantitative analysis and clear, senior-level storytelling that changes minds.  Responsibilities:  Portfolio-wide, cross-indication analysis and strategic projects:  • Act as the Global Analytics & Insights point of contact for the Cell Therapy Enterprise, partnering with cross-functional leaders and priority markets to shape portfolio strategy, asset development plans, and long-range business planning.  • Build personal and institutional knowledge of key disease areas in the space, including HCP and patient insights, market dynamics, competitive landscape, and key implications on the AZ portfolio.  • Lead strategic projects across the cell therapy portfolio in partnership with Cell Therapy Enterprise leadership and cross-functional teams.  • Serve as a cell therapy insights expert, building the capabilities, evidence, and market understanding needed to support clinical development plans, asset prioritization, indication strategy, and future commercialization.  Global Analytics & Insights lead for priority cell therapy assets and indications:  • Develop a deep therapy area knowledge bridging from clinical development through to commercialization.  • Uncover deep strategic understanding of patients, markets, collaborators, competitors, and brands to drive competitive advantage now and for the future.  • Partner strategically with Global Commercial, R&D, Medical, Regulatory, Market Access, and Operations teams, bringing objective insights to key asset and portfolio decisions.  • Provide an independent view in decision-making bodies with an external perspective and a future-oriented focus.  • Integrate insights from clinical, market, customer, competitor, access, and treatment-delivery sources to inform target product profiles, development choices, indication sequencing, portfolio prioritization, and robust opportunity-focused forecasts.  • Develop objective quantitative analyses and business cases that reflect cell therapy-specific considerations, including eligible patient identification, referral pathways, treatment-center readiness, manufacturing capacity, vein-to-vein time, access, and scalability.  • Manage relations